Is carvedilol a CYP3A4 inhibitor?

Is carvedilol a CYP3A4 inhibitor?

The primary P450 enzymes responsible for the metabolism of both R(+) and S(-)-carvedilol in human liver microsomes were CYP2D6 and CYP2C9 and to a lesser extent CYP3A4, 2C19, 1A2, and 2E1. CYP2D6 is thought to be the major enzyme in the 4′- and 5′-hydroxylation of carvedilol, with a potential contribution from 3A4.

What is the mechanism of carvedilol?

Carvedilol inhibits exercise induce tachycardia through its inhibition of beta adrenoceptors. Carvedilol’s action on alpha-1 adrenergic receptors relaxes smooth muscle in vasculature, leading to reduced peripheral vascular resistance and an overall reduction in blood pressure.

What are the physical properties of carvedilol?

Carvedilol is a basic, hydrophobic compound with a steady-state volume of distribution of 115 L. Plasma clearance ranges from 500 to 700 mL/min.

How is Coreg metabolized?

The drug is rapidly absorbed and undergoes extensive first-pass metabolism in the liver. It reaches a peak concentration 1 to 2 hours postdose and has an elimination half-life of about 4 to 7 hours. Absorption is delayed by food. The drug is highly lipophilic and is highly protein bound.

What receptors does carvedilol block?

Conclusions: Carvedilol blocks human cardiac beta2-adrenoceptors more than beta1-adrenoceptors, thereby conceivably contributing to the beneficial effects in heart failure. The persistent blockade of beta-adrenoceptors is attributed to accumulation of carvedilol in cardiac tissue.

Is carvedilol metabolized by CYP2D6?

Carvedilol lowers blood pressure by blocking alpha receptors on blood vessels, which relaxes and dilates blood vessels. CYP2D6 is one of the primary enzymes involved in activating and metabolizing carvedilol.

Is carvedilol a vasodilator?

Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease.

Does carvedilol cause peripheral vasodilation?

Carvedilol reduces peripheral vascular resistance by blocking arterial alpha 1-adrenoceptors, thereby producing vasodilation, while preventing reflex tachycardia by blocking cardiac beta 1- and beta 2-adrenoceptors.

Is carvedilol selective or nonselective?

Carvedilol is a non-selective beta-blocker with α1, β1 and β2 adrenergic receptor blockade properties.

Is carvedilol an inverse agonist?

Ligands that did not stimulate significant cAMP generation were further analyzed for inverse agonism. Each of these (betaxolol, bisoprolol, carvedilol, ICI 118,551, metoprolol, nadolol, propranolol, sotalol, and timolol) decreased constitutive cAMP accumulation and are thus inverse agonists (Fig. 1B).

What is the mechanism of action of labetalol?

Labetalol acts by blocking alpha and beta adrenergic receptors, resulting in decreased peripheral vascular resistance without significant alteration of heart rate or cardiac output.

How does carvedilol work in the heart?

In the heart, carvedilol has approximately 7 times higher potency for beta 1 and beta 2 adre … Carvedilol is an adrenoceptor antagonist which modulates the activity not only of beta 1 and beta 2 but also of alpha 1 adrenergic receptors present on the cell surface membrane of the human cardiac myocyte.

What is the absorption rate of carvedilol?

Carvedilol is rapidly and extensively absorbed following oral administration, with absolute bioavailability of approximately 25 percent to 35 percent due to a significant degree of first-pass metabolism. US Natl Inst Health; DailyMed. Current Medication Information for CARVEDILOL (carvedilol) tablet (May 2011).

Does carvedilol undergo sulfate conjugation before elimination?

Carvedilol and its metabolites may undergo further sulfate conjugation or glucuronidation before elimination. Carvedilol can be O-glucuronidated by UGT1A1, UGT2B4, and UGT2B7 to form carvedilol glucuronide.

How does carvedilol affect the environment?

Carvedilol’s production and use in treatment of congestive heart failure may result in its release to the environment through various waste streams. If released to air, an estimated vapor pressure of 5.9X10-14 mm Hg at 25 °C indicates carvedilol will exist solely in the particulate phase in the atmosphere.